Bioquell earns top award for work in superbug battle

8:10am Thursday 12th March 2009

ANDOVER company Bioquell has won a prestigious award for its bug-busting technology.

The business has developed revolutionary ‘peroxide vapour’ technology in the battle against Clostridium difficile (C-diff), which has won recognition from the Department of Health and the NHS Purchasing and Supply Agency (PASA).

Its award was for innovative technological concept or new and novel product or technology in controlling C-diff.

Matt Parks, head of Bioquell’s UK healthcare decontamination practice, said: “We are thrilled to have won such a prestigious award following many years of hard work carrying out painstaking superbug eradication research in hospitals around the world.

“Winning this award highlights the importance of Bioquell’s presence within the NHS to help combat the threat posed by hospital acquired infection.”

Bioquell’s fully managed decontamination service was recently showcased as one of only six technologies trialled throughout seven UK hospitals. The trials proved that such a service could easily be implemented as part of a hospital’s infection control regime, offering quick turnaround times in the decontamination of infected areas.

Click Here to return to the Main News Page